Top 10 Companies in the 6‑Amino‑Nicotinic Acid Methyl Ester Market (2026): Market Leaders Driving Global Chemical Innovation

Market Size

The Global 6‑Amino‑Nicotinic Acid Methyl Ester market was valued at USD 0.9 million in 2024 and is forecasted to reach USD 1.3 million by 2031, reflecting a compound annual growth rate of 4.9% between 2025 and 2034.

The market is characterized by steady growth, driven by increasing demand in the pharmaceutical industry, particularly for its use in ointments for psoriasis treatment and as an intermediate in chemical synthesis.

Despite its niche market position, 6‑Amino‑Nicotinic Acid Methyl Ester plays a crucial role in advancing drug formulations and chemical product development. The rise in research activities and the growing need for chemical intermediates in the global market are anticipated to contribute to its market expansion.

6‑Amino‑Nicotinic Acid Methyl Ester (CAS# 36052-24-1), also known as 6‑Aminopyridine‑3‑carboxylic Acid Methyl Ester, is a chemical compound primarily used in pharmaceutical applications and as an intermediate in chemical synthesis. It is widely recognized for its role in the production of ointments for the treatment of psoriasis, as well as serving as a key ingredient in various chemical products. This ester is predominantly used in small‑scale applications and research purposes, typically produced at the reagent grade or via contract manufacturing. As a versatile compound, it plays a critical role in advancing pharmaceutical and chemical research, contributing to a wide range of product developments.

Top 10 Companies in the 6‑Amino‑Nicotinic Acid Methyl Ester Market (2026)

6‑Amino‑Nicotinic Acid Methyl Ester Market – View in Detailed Research Report

1. 10️⃣ 1. Zhejiang Zetian Fine Chemical

   Headquarters: Zhejiang, China
   Key Offering: Pharmaceutical intermediates and reagent‑grade 6‑Amino‑Nicotinic Acid Methyl Ester

   Zhejiang Zetian Fine Chemical has established itself as a leading producer in the Asia Pacific region, leveraging its extensive production capacity and cost‑effective manufacturing processes to supply high‑purity reagent‑grade and contract‑manufactured products to global pharmaceutical and chemical customers. The company’s focus on scaling its production base and investing in R&D enables it to maintain a competitive edge in a market driven by evolving therapeutic needs.

   Sustainability and Growth Initiatives:

   • Investments in green chemistry initiatives to reduce solvent usage and waste.
   • Expansion of production capacity in emerging markets to meet rising demand.
   • Strategic partnerships with research institutions to accelerate innovation.

2. 9️⃣ 2. Taizhou Volsen Chemical

   Headquarters: Zhejiang, China
   Key Offering: Fine chemicals and custom‑synthesized intermediates

   Taizhou Volsen Chemical specializes in fine chemical synthesis and custom formulation services, positioning it as a preferred partner for companies seeking tailored solutions in pharmaceutical development.

   Sustainability and Growth Initiatives:

   • Cost‑leadership strategy focused on process efficiency.
   • R&D collaborations with academic and industrial partners.
   • Investment in scalable manufacturing technologies.

3. 8️⃣ 3. Accela ChemBio

   Headquarters: Delaware, USA
   Key Offering: Pharmaceutical intermediates for specialty drugs

   Accela ChemBio operates across North America and Europe, delivering high‑quality intermediates to pharmaceutical manufacturers with a strong emphasis on customer service and technical support.

   Sustainability and Growth Initiatives:

   • Innovation through strategic partnerships with leading pharma companies.
   • Expansion into emerging markets via regional distribution networks.
   • Adoption of eco‑friendly production practices and waste minimization.

4. 7️⃣ 4. BASF AG

   Headquarters: Ludwigshafen, Germany
   Key Offering: Chemical intermediates for diverse industries

   BASF’s global footprint and integrated supply chain enable it to supply 6‑Amino‑Nicotinic Acid Methyl Ester to a broad range of chemical and pharmaceutical customers.

   Sustainability and Growth Initiatives:

   • Commitment to circular economy principles and resource efficiency.
   • Reduction of carbon footprint through renewable energy integration.
   • Investment in renewable feedstock development.

5. 6️⃣ 5. Evonik Industries

   Headquarters: Essen, Germany
   Key Offering: Specialty chemicals and high‑performance intermediates

   Evonik’s expertise in specialty chemicals positions it to offer high‑performance intermediates, including 6‑Amino‑Nicotinic Acid Methyl Ester, to advanced research labs and specialty pharma.

   Sustainability and Growth Initiatives:

   • Focus on sustainable sourcing and lifecycle management.
   • Collaborations with academic partners to explore new applications.
   • Investment in low‑impact manufacturing technologies.

6. 5️⃣ 6. DuPont

   Headquarters: Wilmington, USA
   Key Offering: Advanced chemical solutions for pharma and biotech

   DuPont’s advanced chemical portfolio and global R&D network support the development of high‑purity intermediates for the pharmaceutical sector.

   Sustainability and Growth Initiatives:

   • Innovation in green chemistry and solvent‑free processes.
   • Energy‑efficient manufacturing and supply‑chain transparency.
   • Commitment to responsible sourcing and reporting.

7. 4️⃣ 7. Mitsubishi Chemical

   Headquarters: Tokyo, Japan
   Key Offering: Fine chemicals for specialty applications

   Mitsubishi Chemical’s strong presence in Asia and focus on high‑value chemicals make it a key supplier of 6‑Amino‑Nicotinic Acid Methyl Ester.

   Sustainability and Growth Initiatives:

   • Sustainable manufacturing practices and carbon‑reduction targets.
   • Partnerships with local universities for research development.
   • Integration of renewable feedstocks into production lines.

8. 3️⃣ 8. Linde

   Headquarters: Munich, Germany
   Key Offering: Industrial gases and chemical intermediates

   Linde’s expertise in process gases and chemical intermediates supports the production of high‑purity 6‑Amino‑Nicotinic Acid Methyl Ester.

   Sustainability and Growth Initiatives:

   • Energy‑efficient production and waste minimization.
   • Community engagement and responsible resource use.
   • Continuous improvement of supply‑chain sustainability metrics.

9. 2️⃣ 9. Dow Chemical

   Headquarters: Midland, USA
   Key Offering: Specialty chemicals for pharma and industrial use

   Dow Chemical’s extensive R&D and global distribution network enable it to supply 6‑Amino‑Nicotinic Acid Methyl Ester to a wide range of industries.

   Sustainability and Growth Initiatives:

   • Circular economy initiatives and reduced chemical usage.
   • Sustainability reporting and stakeholder engagement.
   • Investment in low‑carbon process technologies.

10. 1️⃣ 10. Sumitomo Chemical

    Headquarters: Osaka, Japan
    Key Offering: Chemical intermediates for pharmaceutical and specialty markets

    Sumitomo Chemical’s integrated manufacturing and global logistics allow it to deliver high‑quality intermediates to pharmaceutical and chemical customers worldwide.

    Sustainability and Growth Initiatives:

    • Eco‑friendly production and low‑carbon processes.
    • Innovation in renewable feedstocks and green chemistry.
    • Stakeholder collaboration for sustainable development.

Download FREE Sample Report
Get Full Report

Outlook: The Future of 6‑Amino‑Nicotinic Acid Methyl Ester Market

The market is expected to remain resilient as pharmaceutical companies continue to seek high‑quality intermediates for dermatological therapies and as chemical synthesis expands into new sectors. Companies that invest in sustainable manufacturing, digital supply‑chain integration, and collaborative R&D are likely to capture the largest share of growth.

Future Trends

• Expansion of research into advanced psoriasis treatments, creating new demand for the ester.
• Integration of the compound into personalized medicine formulations, driven by patient‑specific therapeutic strategies.
• Adoption of eco‑friendly production routes, including renewable feedstocks and closed‑loop processes.
• Growth in emerging economies, particularly in Asia Pacific, where pharmaceutical manufacturing is scaling rapidly.